Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: Studies with chimeric receptors

Molecular Pharmacology

Volumn 58, Issue 6, 2000, Pages 1451-1460

  Ellis, John ^a,b   Seidenberg, Margaret ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; 6 CHLORO 5,10 DIHYDRO 5 [(1 METHYL 4 PIPERIDYL)ACETYL] 11H DIBENZO[B,E][1,4]DIAZEPIN 11 ONE; ALCURONIUM; GALLAMINE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; OBIDOXIME; RECEPTOR SUBTYPE; TACRINE; TUBOCURARINE CHLORIDE; VERAPAMIL;

ALLOSTERISM; CHIMERA; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY; SHORT SURVEY;

EID: 0033664285     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.6.1451     Document Type: Short Survey

References (36)

1. The effects of ions on the binding of agonists and antagonists to muscarinic receptors
2. Allosteric regulation of G-protein-linked receptors
3. Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes
4. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes
5. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors
6. Allosteric interactions at muscarinic cholinoceptors
7. Propylbenzilylcholine mustard labels an acidic residue in transmembrane helix 3 of the muscarinic receptor
8. 'Inverse agonists', cooperativity, and drug action at benzodiazepine receptors
9. Allosteric binding sites on muscarinic receptors
10. Allceteric regulation of cloned m1-m5 muscarinic receptor subtypes
11. Two allosteric modulators interact at a common site on cardiac muscarinic receptors
12. Competitive and allosteric interactions of 6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11H-di benzo[b, e] [1, 4]diazepine-11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopes
13. Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype-selectivities of UH-AH 37 and pirenzepine at muscarinic receptors
14. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions
15. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: Conserved aspartic acids play important roles in receptor function
16. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors
17. Regulation of D2 dopamine receptors by amiloride and amiloride analogs
18. Localization of the ligand binding site of the neurokinin-1 receptor: Interpretation of chimeric mutations and single-residue substitutions
19. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors
20. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium
21. Muscarinic Acetylcholine Receptors
22. Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation
23. Allosteric antagonists of the muscarinic acetylcholine receptor
24. Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor
25. Characterization of the allosteric interactions between antagonists and amiloride analogues at the human alpha2A-adrenergic receptor
26. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor
27. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis
28. Allosteric effects of the alkane-bis-ammonium compound W84 and of tacrine on [3H]pirenzepine binding at M1-receptors in rat cerebral cortex
29. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors
30. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors
31. Competition between positive and negative allosteric effectors on muscarinic receptors
32. How receptor mutagenesis may confirm or confuse receptor classification
33. Search for lead structures to develop new allosteric modulators of muscarinic receptors
34. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors
35. Binding, partial agonism, and potentiation of alpha(1)-adrenergic receptor function by benzodiazepines: A potential site of allosteric modulation
36. Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers